Prognostic value of PTEN loss in men with conservatively managed localised prostate cancer-Reference-Cited by-同舟云学术

Prognostic value of PTEN loss in men with conservatively managed localised prostate cancer

Published:2013-05-21 Issue:12 Volume:108 Page:2582-2589
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Cuzick J, ,Yang Z H,Fisher G,Tikishvili E,Stone S,Lanchbury J S,Camacho N,Merson S,Brewer D,Cooper C S,Clark J,Berney D M,Møller H,Scardino P,Sangale Z

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc2013248.pdf

Reference25 articles.

1. Antonarakis ES, Keizman D, Zhang Z, Gurel B, Lotan TL, Hicks JL, Fedor HL, Carducci MA, De Marzo AM, Eisenberger MA (2012) An immunohistochemical signature comprising PTEN, MYC, and Ki67 predicts progression in prostate cancer patients receiving adjuvant docetaxel after prostatectomy. Cancer 118 (24): 6063–6071.

2. Attard G, Clark J, Ambroisine L, Fisher G, Kovacs G, Flohr P, Berney D, Foster CS, Fletcher A, Gerald WL, Moller H, Reuter V, De Bono JS, Scardino P, Cuzick J, Cooper CS Transatlantic Prostate Group (2008) Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer. Oncogene 27 (3): 253–263.

3. Bedolla R, Prihoda TJ, Kreisberg JI, Malik SN, Krishnegowda NK, Troyer DA, Ghosh PM (2007) Determining risk of biochemical recurrence in prostate cancer by immunohistochemical detection of PTEN expression and Akt activation. Clin Cancer Res 13 (13): 3860–3867.

4. Berney DM, Gopalan A, Kudahetti S, Fisher G, Ambroisine L, Foster CS, Reuter V, Eastham J, Moller H, Kattan MW, Gerald W, Cooper C, Scardino P, Cuzick J (2009) Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate group study. Br J Cancer 100: 888–893.

5. Cuzick J, Fisher G, Kattan MW, Berney D, Oliver T, Foster CS, Møller H, Reuter V, Fearn P, Eastham J, Scardino P and the Transatlantic Prostate Group (2006) Long-term outcome among men with conservatively treated localised prostate cancer. Br J Cancer 95 (9): 1186–1194.

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DNA ploidy and PTEN as biomarkers for predicting aggressive disease in prostate cancer patients under active surveillance;British Journal of Cancer;2024-07-03

2. Small cell neuroendocrine prostate cancer with adenocarcinoma components—case report and literature review;Translational Andrology and Urology;2024-05

3. Predicting Prostate Cancer Molecular Subtype With Deep Learning on Histopathologic Images;Modern Pathology;2023-10

4. Simultaneous Thoracic Spine Metastatic Melanoma and Pre-existing Prostate Adenocarcinoma: A Unique Case Presentation and Literature Review;Cureus;2023-08-13

5. Correlations of PTEN and ERG Immunoexpression in Prostate Carcinoma and Lesions Related to Its Natural History: Clinical Perspectives;Current Issues in Molecular Biology;2023-03-25